Nanocarriers for gene delivery - Polymer structure, targeting ligands and controlled-release devices

Current Nanoscience

Volumn 4, Issue 4, 2008, Pages 322-353

  Elfinger, Markus ^a,b   Üzün, Senta ^a,b   Rudolph, Carsten ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Controlled release; Gene delivery; Nanoparticles; Polymer; Targeting

Indexed keywords

AMINO ESTERS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL PROPERTIES; CATIONIC COMPLEXES; CONTROLLED RELEASE; DNA DEGRADATION; GENE DELIVERY; GENE DELIVERY SYSTEMS; GENE THERAPY; GENETIC MATERIALS; IMMUNOGENICITY; IN-SITU FORMING; INSERTIONAL MUTAGENESIS; NANOCARRIERS; NONVIRAL; NONVIRAL VECTORS; POLY LACTIDE-CO-GLYCOLIDE; POLYCATIONS; POLYETHYLENIMINES; POLYMER STRUCTURE; POLYPLEXES; REDUCED TOXICITY; SAFETY CONCERNS; SLOW RELEASE; TARGETING; THERAPEUTIC USE; VIRAL VECTORS;

AMINES; BIOCOMPATIBILITY; BIODEGRADATION; DENDRIMERS; DNA; DYES; ESTERS; GENE EXPRESSION; GENE TRANSFER; GLUCOSE; LIGANDS; NANOPARTICLES; NUCLEIC ACIDS; RNA; VECTORS;

BIODEGRADABLE POLYMERS;

ALGINIC ACID; ANGIOGENESIS INHIBITOR; ATELOCOLLAGEN; CHITIN; CHLOROQUINE; DENDRIMER; DEXTRAN; FIBRIN; FIBROBLAST GROWTH FACTOR 4; GENTAMICIN; HYALURONIC ACID; HYDROXYPROPYLMETHYLCELLULOSE; LEUPRORELIN; LIPOSOME; NANOCARRIER; NK 4; PARATHYROID HORMONE; PLASMID DNA; PLATELET DERIVED GROWTH FACTOR; POLYETHYLENEIMINE; POLYGLACTIN; POLYLYSINE; THROMBOPOIETIN; UNCLASSIFIED DRUG;

ARTIFICIAL CHROMOSOME; BIOCOMPATIBILITY; BIODEGRADABILITY; CANCER GENE THERAPY; CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CYTOTOXICITY; DNA DEGRADATION; ENCAPSULATION; GENE EXPRESSION; GENE GUN; GENE TARGETING; HUMAN; HYDRODYNAMICS BASED TRANSFECTION; IMMUNOGENICITY; INTERNALIZATION; LIMB ISCHEMIA; LIPOSOMAL GENE DELIVERY SYSTEM; NANOFABRICATION; NANOPHARMACEUTICS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SLOW RELEASE FORMULATION; THROMBOCYTOPENIA; TISSUE ENGINEERING; TISSUE REGENERATION; TUMOR;

EID: 65749120721     PISSN: 15734137     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341308786306062     Document Type: Review

References (381)

1. Kasuga, M.; Liu, Q.; Miura, S.; Yamaguchi-Shinozaki, K.; Shinozaki, K. Improving plant drought, salt, and freezing tolerance by gene transfer of a single stress-inducible transcription factor. Nat. Biotechnol., 1999, 17(3), 287.
2. Dale, E.C.; Ow, D.W. Gene transfer with subsequent removal of the selection gene from the host genome. Proc. Natl. Acad. Sci. USA., 1991, 88 (23), 10558.
3. Hayakawa, T.; Zhu, Y.; Itoh, K.; Kimura, Y.; Izawa, T.; Shimamoto, K.; Toriyama, S. Genetically engineered rice resistant to rice stripe virus, an insect-transmitted virus. Proc. Natl. Acad. Sci. USA., 1992, 89 (20), 9865.
4. Anderson, W.F. Human gene therapy. Nature, 1998, 392 (6679 Suppl), 25.
5. Mahato, R.I.; Smith, L.C.; Rolland, A. Pharmaceutical perspectives of nonviral gene therapy. Adv. Genet., 1999, 41, 95.
6. Gardlik, R.; Palffy, R.; Hodosy, J.; Lukacs, J.; Turna, J.; Celec, P. Vectors and delivery systems in gene therapy. Med. Sci. Monit., 2005, 11(4), RA110.
7. Curiel, D.T.; Agarwal, S.; Wagner, E.; Cotten, M. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc. Natl. Acad. Sci. USA., 1991, 88 (19), 8850.
8. Lehrman, S. Virus treatment questioned after gene therapy death. Nature, 1999, 401 (6753), 517.
9. Raper, S.E.; Chirmule, N.; Lee, F.S.; Wivel, N.A.; Bagg, A.; Gao, G.P.; Wilson, J.M.; Batshaw, M.L. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab., 2003, 80 (1-2), 148.
10. Themis, M.; Waddington, S.N.; Schmidt, M.; von Kalle, C.; Wang, Y.; Al-Allaf, F.; Gregory, L.G.; Nivsarkar, M.; Themis, M.; Holder, M.V.; Buckley, S.M.; Dighe, N.; Ruthe, A.T.; Mistry, A.; Bigger, B.; Rahim, A.; Nguyen, T.H.; Trono, D.; Thrasher, A.J.; Coutelle, C. Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. Mol. Ther., 2005, 12 (4), 763.
11. Hacein-Bey-Abina, S.; Von Kalle, C.; Schmidt, M.; McCormack, M.P.; Wulffraat, N.; Leboulch, P.; Lim, A.; Osborne, C.S.; Pawliuk, R.; Morillon, E.; Sorensen, R.; Forster, A.; Fraser, P.; Cohen, J.I.; de Saint Basile, G.; Alexander, I.; Wintergerst, U.; Frebourg, T.; Aurias, A.; Stoppa-Lyonnet, D.; Romana, S.; Radford-Weiss, I.; Gross, F.; Valensi, F.; Delabesse, E.; Macintyre, E.; Sigaux, F.; Soulier, J.; Leiva, L.E.; Wissler, M.; Prinz, C.; Rabbitts, T.H.; Le Deist, F.; Fischer, A.; Cavazzana-Calvo, M. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science, 2003, 302 (5644), 415.
12. Schatzlein, A.G. Non-viral vectors in cancer gene therapy: principles and progress. Anticancer Drugs, 2001, 12 (4), 275.
13. Choi, Y.H.; Liu, F.; Kim, J.S.; Choi, Y.K.; Park, J.S.; Kim, S.W. Polyethylene glycol-grafted poly-L-lysine as polymeric gene carrier. J. Control. Release, 1998, 54 (1), 39.
14. Dash, P.R.; Read, M.L.; Barrett, L.B.; Wolfert, M.A.; Seymour, L.W. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther., 1999, 6 (4), 643.
15. Jiao, S.; Williams, P.; Berg, R.K.; Hodgeman, B.A.; Liu, L.; Repetto, G.; Wolff, J.A. Direct gene transfer into nonhuman primate myofibers in vivo. Hum. Gene. Ther., 1992, 3 (1), 21.
16. Wolff, J.A.; Malone, R.W.; Williams, P.; Chong, W.; Acsadi, G.; Jani, A.; Felgner, P.L. Direct gene transfer into mouse muscle in vivo. Science, 1990, 247 (4949 Pt 1), 1465.
17. Hickman, M.A.; Malone, R.W.; Lehmann-Bruinsma, K.; Sih, T.R.; Knoell, D.; Szoka, F.C.; Walzem, R.; Carlson, D.M.; Powell, J.S. Gene expression following direct injection of DNA into liver. Hum. Gene. Ther., 1994, 5 (12), 1477.
18. Zhang, G.; Vargo, D.; Budker, V.; Armstrong, N.; Knechtle, S.; Wolff, J.A. Expression of naked plasmid DNA injected into the afferent and efferent vessels of rodent and dog livers. Hum. Gene Ther., 1997, 8 (15), 1763.
19. Ardehali, A.; Fyfe, A.; Laks, H.; Drinkwater, D.C., Jr.; Qiao, J.H.; Lusis, A.J. Direct gene transfer into donor hearts at the time of harvest. J. Thorac. Cardiovasc. Surg., 1995, 109 (4), 716; discussion 719.
20. Vile, R.G.; Hart, I.R. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res., 1993, 53 (17), 3860.
21. Yang, J.P.; Huang, L. Direct gene transfer to mouse melanoma by intratumor injection of free DNA. Gene Ther., 1996, 3 (6), 542.
22. Yu, W.H.; Kashani-Sabet, M.; Liggitt, D.; Moore, D.; Heath, T.D.; Debs, R.J. Topical gene delivery to murine skin. J. Invest. Dermatol., 1999, 112 (3), 370.
23. Barry, M.E.; Pinto-Gonzalez, D.; Orson, F.M.; McKenzie, G.J.; Petry, G.R.; Barry, M.A. Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. Hum. Gene Ther., 1999, 10 (15), 2461.
24. Liu, F.; Song, Y.; Liu, D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther., 1999, 6 (7), 1258.
25. Habib, N. Clinical Study with Hydrodynamic Gene Delivery into Hepatocytes in Humans. ASGT, 9th Annual Meeting, Executive Summaries, 2006, 36.
26. Kuriyama, S.; Mitoro, A.; Tsujinoue, H.; Nakatani, T.; Yoshiji, H.; Tsujimoto, T.; Yamazaki, M.; Fukui, H. Particle-mediated gene transfer into murine livers using a newly developed gene gun. Gene Ther., 2000, 7 (13), 1132.
27. Aihara, H.; Miyazaki, J. Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol., 1998, 16 (9), 867.
28. Plank, C.; Schillinger, U.; Scherer, F.; Bergemann, C.; Remy, J.S.; Krotz, F.; Anton, M.; Lausier, J.; Rosenecker, J. The magnetofection method: using magnetic force to enhance gene delivery. Biol. Chem., 2003, 384 (5), 737.
29. Scherer, F.; Anton, M.; Schillinger, U.; Henke, J.; Bergemann, C.; Kruger, A.; Gansbacher, B.; Plank, C. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther., 2002, 9 (2), 102.
30. Huth, S.; Lausier, J.; Gersting, S.W.; Rudolph, C.; Plank, C.; Welsch, U.; Rosenecker, J. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J. Gene Med., 2004, 6 (8), 923.
31. Felgner, P.L.; Gadek, T.R.; Holm, M.; Roman, R.; Chan, H.W.; Wenz, M.; Northrop, J.P.; Ringold, G.M.; Danielsen, M. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA, 1987, 84 (21), 7413.
32. Porteous, D.J.; Dorin, J.R.; McLachlan, G.; Davidson-Smith, H.; Davidson, H.; Stevenson, B.J.; Carothers, A.D.; Wallace, W.A.; Moralee, S.; Hoenes, C.; Kallmeyer, G.; Michaelis, U.; Naujoks, K.; Ho, L.P.; Samways, J.M.; Imrie, M.; Greening, A.P.; Innes, J.A. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther., 1997, 4 (3), 210.
33. Laitinen, M.; Hartikainen, J.; Hiltunen, M.O.; Eranen, J.; Kiviniemi, M.; Narvanen, O.; Makinen, K.; Manninen, H.; Syvanne, M.; Martin, J.F.; Laakso, M.; Yla-Herttuala, S. Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Hum. Gene. Ther., 2000, 11 (2), 263.
34. Huang, C. Studies on phosphatidylcholine vesicles. Formation and physical characteristics. Biochemistry, 1969, 8 (1), 344.
35. Jiskoot, W.; Teerlink, T.; Beuvery, E.C.; Crommelin, D.J. Preparation of liposomes via detergent removal from mixed micelles by dilution. The effect of bilayer composition and process parameters on liposome characteristics. Pharm. Weekbl. Sci., 1986, 8 (5), 259.
36. Mayer, L.D.; Hope, M.J.; Cullis, P.R. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim. Biophys. Acta, 1986, 858 (1), 161.
37. Zhdanov, R.I.; Podobed, O.V.; Vlassov, V.V. Cationic lipid-DNA complexes-lipoplexes-for gene transfer and therapy. Bioelectrochemistry, 2002, 58 (1), 53.
38. Monck, M.A.; Mori, A.; Lee, D.; Tam, P.; Wheeler, J.J.; Cullis, P.R.; Scherrer, P. Stabilized plasmid-lipid particles: pharmacokinetics and plasmid delivery to distal tumors following intravenous injection. J. Drug Target., 2000, 7 (6), 439.
39. Radler, J.O.; Koltover, I.; Salditt, T.; Safinya, C.R. Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science, 1997, 275 (5301), 810.
40. Sternberg, B.; Sorgi, F.L.; Huang, L. New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy. FEBS Lett., 1994, 356 (2-3), 361.
41. Labat-Moleur, F.; Steffan, A.M.; Brisson, C.; Perron, H.; Feugeas, O.; Furstenberger, P.; Oberling, F.; Brambilla, E.; Behr, J.P. An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther., 1996, 3 (11), 1010.
42. Song, Y.K.; Liu, F.; Chu, S.; Liu, D. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum. Gene Ther., 1997, 8 (13), 1585.
43. Templeton, N.S.; Lasic, D.D.; Frederik, P.M.; Strey, H.H.; Roberts, D.D.; Pavlakis, G.N. Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat. Biotechnol., 1997, 15 (7), 647.
44. Almofti, M.R.; Harashima, H.; Shinohara, Y.; Almofti, A.; Baba, Y.; Kiwada, H. Cationic liposome-mediated gene delivery: biophysical study and mechanism of internalization. Arch. Biochem. Biophys., 2003, 410 (2), 246.
45. Farhood, H.; Serbina, N.; Huang, L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta, 1995, 1235 (2), 289.
46. Mounkes, L.C.; Zhong, W.; Cipres-Palacin, G.; Heath, T.D.; Debs, R.J. Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. J. Biol. Chem., 1998, 273 (40), 26164.
47. Wheeler, C.J.; Sukhu, L.; Yang, G.; Tsai, Y.; Bustamente, C.; Felgner, P.; Norman, J.; Manthorpe, M. Converting an alcohol to an amine in a cationic lipid dramatically alters the co-lipid requirement, cellular transfection activity and the ultrastructure of DNA-cytofectin complexes. Biochim. Biophys. Acta, 1996, 1280 (1), 1.
48. Remy, J.S.; Sirlin, C.; Vierling, P.; Behr, J.P. Gene transfer with a series of lipophilic DNA-binding molecules. Bioconjug. Chem., 1994, 5 (6), 647.
49. Zou, Y.; Zong, G.; Ling, Y.H.; Perez-Soler, R. Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer. Cancer Gene Ther., 2000, 7 (5), 683.
50. Balasubramaniam, R.P.; Bennett, M.J.; Aberle, A.M.; Malone, J.G.; Nantz, M.H.; Malone, R.W. Structural and functional analysis of cationic transfection lipids: the hydrophobic domain. Gene Ther., 1996, 3 (2), 163.
51. Simberg, D.; Danino, D.; Talmon, Y.; Minsky, A.; Ferrari, M.E.; Wheeler, C.J.; Barenholz, Y. Phase behavior, DNA ordering, and size instability of cationic lipoplexes. Relevance to optimal transfection activity. J. Biol. Chem., 2001, 276 (50), 47453.
52. Wang, J.; Guo, X.; Xu, Y.; Barron, L.; Szoka, F.C., Jr. Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery. J. Med. Chem., 1998, 41(13), 2207.
53. Barron, L.G.; Gagne, L.; Szoka, F.C., Jr. Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration. Hum. Gene Ther., 1999, 10 (10), 1683.
54. Li, S.; Huang, L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther., 1997, 4(9), 891.
55. Anwer, K.; Kao, G.; Proctor, B.; Rolland, A.; Sullivan, S. Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions. J. Drug Target., 2000, 8 (2), 125.
56. Matsuo, T.; Masuda, I.; Yasuda, T.; Matsuo, N. Gene transfer to the retina of rat by liposome eye drops. Biochem. Biophys. Res. Commun., 1996, 219 (3), 947.
57. Berry, M.; Gonzalez, A.M.; Clarke, W.; Greenlees, L.; Barrett, L.; Tsang, W.; Seymour, L.; Bonadio, J.; Logan, A.; Baird, A. Sustained effects of gene-activated matrices after CNS injury. Mol. Cell. Neurosci., 2001, 17 (4), 706.
58. De Smedt, S.C.; Demeester, J.; Hennink, W.E. Cationic polymer based gene delivery systems. Pharm. Res., 2000, 17 (2), 113.
59. Felgner, P.L.; Barenholz, Y.; Behr, J.P.; Cheng, S.H.; Cullis, P.; Huang, L.; Jessee, J.A.; Seymour, L.; Szoka, F.; Thierry, A.R.; Wagner, E.; Wu, G. Nomenclature for synthetic gene delivery systems. Hum. Gene Ther., 1997, 8 (5), 511.
60. Behr, J.P. Gene transfer with synthetic cationic amphiphiles: prospects for gene therapy. Bioconjug. Chem., 1994, 5 (5), 382.
61. Akinc, A.; Lynn, D.M.; Anderson, D.G.; Langer, R. Parallel synthesis and biophysical characterization of a degradable polymer library for gene delivery. J. Am. Chem. Soc., 2003, 125 (18), 5316.
62. Boussif, O.; Lezoualch, F.; Zanta, M.A.; Mergny, M.D.; Scherman, D.; Demeneix, B.; Behr, J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA, 1995, 92 (16), 7297.
63. Suh, J.; Paik, H.-J.; Hwang, B.K. Ionization of poly(ethylenimine) and poly (allylamine) at various pH's. Bioorg. Chem., 1994, 22 (3), 318.
64. Sonawane, N.D.; Szoka, F.C., Jr.; Verkman, A.S. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J. Biol. Chem., 2003, 278 (45), 44826.
65. Dunlap, D.D.; Maggi, A.; Soria, M.R.; Monaco, L. Nanoscopic structure of DNA condensed for gene delivery. Nucleic Acids Res., 1997, 25 (15), 3095.
66. Godbey, W.T.; Wu, K.K.; Mikos, A.G. Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials, 2001, 22 (5), 471.
67. Fischer, D.; Li, Y.; Ahlemeyer, B.; Krieglstein, J.; Kissel, T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials, 2003, 24 (7), 1121.
68. Yang, Y.; Jia, W.; Qi, X.; Yang, C.; Liu, L.; Zhang, Z.; Ma, J.; Zhou, S.; Li, X. Novel biodegradable polymers as gene carriers. Macromol. Biosci., 2004, 4 (12), 1113.
69. Fischer, D.; Bieber, T.; Li, Y.; Elsasser, H.P.; Kissel, T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm. Res., 1999, 16 (8), 1273.
70. Thomas, M.; Ge, Q.; Lu, J.J.; Chen, J.; Klibanov, A.M. Cross-linked small polyethylenimines: while still nontoxic, deliver DNA efficiently to mammalian cells in vitro and in vivo. Pharm. Res., 2005, 22 (3), 373.
71. Tang, G.P.; Zeng, J.M.; Gao, S.J.; Ma, Y.X.; Shi, L.; Li, Y.; Too, H.P.; Wang, S. Polyethylene glycol modified polyethylenimine for improved CNS gene transfer: effects of PEGylation extent. Biomaterials, 2003, 24(13), 2351.
72. Ogris, M.; Walker, G.; Blessing, T.; Kircheis, R.; Wolschek, M.; Wagner, E. Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J. Control. Release, 2003, 91(1-2), 173.
73. Goula, D.; Benoist, C.; Mantero, S.; Merlo, G.; Levi, G.; Demeneix, B.A. Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther., 1998, 5(9), 1291.
74. Ogris, M.; Brunner, S.; Schuller, S.; Kircheis, R.; Wagner, E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther., 1999, 6(4), 595.
75. Plank, C.; Mechtler, K.; Szoka, F.C., Jr.; Wagner, E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum. Gene Ther., 1996, 7 (12), 1437.
76. Rudolph, C.; Schillinger, U.; Ortiz, A.; Plank, C.; Golas, M.M.; Sander, B.; Stark, H.; Rosenecker, J. Aerosolized nanogram quantities of plasmid DNA mediate highly efficient gene delivery to mouse airway epithelium. Mol. Ther., 2005, 12 (3), 493.
77. Gautam, A.; Densmore, C.L.; Waldrep, J.C. Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy. Gene Ther., 2001, 8 (3), 254.
78. Ohana, P.; Gofrit, O.; Ayesh, S.; Al-Sharef, W.; Mizrahi, A.; Birman, T.; Schneider, T.; Matouk, I.; de Groot, N.; Tavdy, E.; Sidi, A.A.; Hochberg, A. Regulatory sequences of the H19 gene in DNA based therapy of bladder cancer. Gene Ther. Mol. Biol., 2004, 8, 181.
79. Wu, G.Y.; Wu, C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem., 1987, 262(10), 4429.
80. Kwoh, D.Y.; Coffin, C.C.; Lollo, C.P.; Jovenal, J.; Banaszczyk, M.G.; Mullen, P.; Phillips, A.; Amini, A.; Fabrycki, J.; Bartholomew, R.M.; Brostoff, S.W.; Carlo, D.J. Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver. Biochim. Biophys. Acta, 1999, 1444(2), 171.
81. Lucas, P.; Milroy, D.A.; Thomas, B.J.; Moss, S.H.; Pouton, C.W. Pharmaceutical and biological properties of poly(amino acid)/DNA polyplexes. J. Drug Target., 1999, 7(2), 143.
82. Wagner, E.; Plank, C.; Zatloukal, K.; Cotten, M.; Birnstiel, M.L. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc. Natl. Acad. Sci. USA, 1992, 89(17), 7934.
83. Pouton, C.W.; Lucas, P.; Thomas, B.J.; Uduehi, A.N.; Milroy, D.A.; Moss, S.H. Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. J. Control. Release, 1998, 53(1-3), 289.
84. Wolfert, M.A.; Seymour, L.W. Chloroquine and amphipathic peptide helices show synergistic transfection in vitro. Gene Ther., 1998, 5 (3), 409.
85. Midoux, P.; Monsigny, M. Efficient gene transfer by histidylated polylysine/pDNA complexes. Bioconjug. Chem., 1999, 10 (3), 406.
86. Pack, D.W.; Putnam, D.; Langer, R. Design of imidazole-containing endosomolytic biopolymers for gene delivery. Biotechnol. Bioeng., 2000, 67 (2), 217.
87. Lee, H.; Jeong, J.H.; Park, T.G. PEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity. J. Control. Release, 2002, 79 (1-3), 283.
88. Ward, C.M.; Pechar, M.; Oupicky, D.; Ulbrich, K.; Seymour, L.W. Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate-mediated targeting in vitro and prolonged plasma circulation in vivo. J. Gene Med., 2002, 4 (5), 536.
89. Faraasen, S.; Voros, J.; Csucs, G.; Textor, M.; Merkle, H.P.; Walter, E. Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(L-lysine)-grafted poly(ethylene glycol) conjugate. Pharm. Res., 2003, 20 (2), 237.
90. Mannisto, M.; Vanderkerken, S.; Toncheva, V.; Elomaa, M.; Ruponen, M.; Schacht, E.; Urtti, A. Structure-activity relationships of poly(L-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery. J. Control. Release, 2002, 83 (1), 169.
91. Nishikawa, M.; Takemura, S.; Takakura, Y.; Hashida, M. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties. J. Pharmacol. Exp. Ther., 1998, 287 (1), 408.
92. Wolfert, M.A.; Dash, P.R.; Nazarova, O.; Oupicky, D.; Seymour, L.W.; Smart, S.; Strohalm, J.; Ulbrich, K. Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA. Bioconjug. Chem., 1999, 10 (6), 993.
93. Brown, M.D.; Schatzlein, A.; Brownlie, A.; Jack, V.; Wang, W.; Tetley, L.; Gray, A.I.; Uchegbu, I.F. Preliminary characterization of novel amino acid based polymeric vesicles as gene and drug delivery agents. Bioconjug. Chem., 2000, 11 (6), 880.
94. Wolfert, M.A.; Schacht, E.H.; Toncheva, V.; Ulbrich, K.; Nazarova, O.; Seymour, L.W. Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers. Hum. Gene Ther., 1996, 7 (17), 2123.
95. Toncheva, V.; Wolfert, M.A.; Dash, P.R.; Oupicky, D.; Ulbrich, K.; Seymour, L.W.; Schacht, E.H. Novel vectors for gene delivery formed by self-assembly of DNA with poly(L-lysine) grafted with hydrophilic polymers. Biochim. Biophys. Acta, 1998, 1380 (3), 354.
96. Ward, C.M.; Read, M.L.; Seymour, L.W. Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. Blood, 2001, 97 (8), 2221.
97. Dash, P.R.; Read, M.L.; Fisher, K.D.; Howard, K.A.; Wolfert, M.; Oupicky, D.; Subr, V.; Strohalm, J.; Ulbrich, K.; Seymour, L.W. Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin. J. Biol. Chem., 2000, 275 (6), 3793.
98. Konstan, M.W.; Davis, P.B.; Wagener, J.S.; Hilliard, K.A.; Stern, R.C.; Milgram, L.J.; Kowalczyk, T.H.; Hyatt, S.L.; Fink, T.L.; Gedeon, C.R.; Oette, S.M.; Payne, J.M.; Muhammad, O.; Ziady, A.G.; Moen, R.C.; Cooper, M.J. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum. Gene Ther., 2004, 15 (12), 1255.
99. Zhao, Z.; Wang, J.; Mao, H.Q.; Leong, K.W. Polyphosphoesters in drug and gene delivery. Adv. Drug Deliv. Rev., 2003, 55 (4), 483.
100. Luten, J.; van Steenis, J.H.; van Someren, R.; Kemmink, J.; Schuurmans-Nieuwenbroek, N.M.; Koning, G.A.; Crommelin, D.J.; van Nostrum, C.F.; Hennink, W.E. Water-soluble biodegradable cationic polyphosphazenes for gene delivery. J. Control. Release, 2003, 89 (3), 483.
101. Lynn, D.M.; Langer, R. Degradable Poly(b-amino esters): Synthesis, characterization, and self-assembly with plasmid DNA. J. Am. Chem. Soc., 2000, 122, 10761.
102. Anderson, D.G.; Akinc, A.; Hossain, N.; Langer, R. Structure/property studies of polymeric gene delivery using a library of poly(beta-amino esters). Mol. Ther., 2005, 11 (3), 426.
103. Anderson, D.G.; Lynn, D.M.; Langer, R. Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew. Chem. Int. Ed. Engl., 2003, 42 (27), 3153.
104. Tomalia, D.A.; Baker, H.; Dewald, J.; Hall, M.; Kallos, G.; Martin, S.; Roeck, J.; Ryder, J.; Smith, P. New class of polymers: Starbust-dentritic macromolecules. Polymer J., 1984, 17 (1), 117.
105. Grayson, S.M.; Frechet, J.M. Convergent dendrons and dendrimers: from synthesis to applications. Chem. Rev., 2001, 101 (12), 3819.
106. Ramaswamy, C.; Sakthivel, T.; Wilderspin, A.F.; Florence, A.T. Dendriplexes and their characterisation. Int. J. Pharm., 2003, 254 (1), 17.
107. Bielinska, A.U.; Kukowska-Latallo, J.F.; Baker, J.R., Jr. The interaction of plasmid DNA with polyamidoamine dendrimers: mechanism of complex formation and analysis of alterations induced in nuclease sensitivity and transcriptional activity of the complexed DNA. Biochim. Biophys. Acta, 1997, 1353 (2), 180.
108. Bielinska, A.U.; Chen, C.; Johnson, J.; Baker, J.R., Jr. DNA complexing with polyamidoamine dendrimers: implications for transfection. Bioconjug. Chem., 1999, 10 (5), 843.
109. Tang, M.X.; Szoka, F.C. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther., 1997, 4 (8), 823.
110. Manunta, M.; Tan, P.H.; Sagoo, P.; Kashefi, K.; George, A.J. Gene delivery by dendrimers operates via a cholesterol dependent pathway. Nucleic Acids Res., 2004, 32 (9), 2730.
111. Haensler, J.; Szoka, F.C., Jr. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug. Chem., 1993, 4 (5), 372.
112. Esfand, R.; Tomalia, D.A. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov. Today, 2001, 6 (8), 427.
113. Hussain, M.; Shchepinov, M.; Sohail, M.; Benter, I.F.; Hollins, A.J.; Southern, E.M.; Akhtar, S. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides. J. Control. Release, 2004, 99 (1), 139.
114. Mumper, R.J.; Wang, J.; Claspell, J.M.; Rolland, A.P. Novel polymeric condensing carriers for gene delivery. Proc. Intern. Symp. Control. Rel. Bioact. Mater., 1995, 22, 178.
115. Berger, J.; Reist, M.; Mayer, J.M.; Felt, O.; Gurny, R. Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications. Eur. J. Pharm. Biopharm., 2004, 57 (1), 35.
116. Richardson, S.C.; Kolbe, H.V.; Duncan, R. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int. J. Pharm., 1999, 178 (2), 231.
117. MacLaughlin, F.C.; Mumper, R.J.; Wang, J.; Tagliaferri, J.M.; Gill, I.; Hinchcliffe, M.; Rolland, A.P. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J. Control. Release, 1998, 56 (1-3), 259.
118. Thanou, M.; Florea, B.I.; Geldof, M.; Junginger, H.E.; Borchard, G. Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials, 2002, 23 (1), 153.
119. Danielsen, S.; Varum, K.M.; Stokke, B.T. Structural analysis of chitosan mediated DNA condensation by AFM: influence of chitosan molecular parameters. Biomacromolecules, 2004, 5 (3), 928.
120. Mao, H.Q.; Roy, K.; Troung-Le, V.L.; Janes, K.A.; Lin, K.Y.; Wang, Y.; August, J.T.; Leong, K.W. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Control. Release, 2001, 70 (3), 399.
121. Mao, H.Q.; Roy, K.; Truong-Le, V.L.; Leong, K.W. DNA-chitosan nanospheres: Derivatization and storage stability. Proc. Control. Release Soc., 1997, 24, 671.
122. Corsi, K.; Chellat, F.; Yahia, L.; Fernandes, J.C. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials, 2003, 24 (7), 1255.
123. Sato, T.; Ishii, T.; Okahata, Y. In vitro gene delivery mediated by chitosan. effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials, 2001, 22 (15), 2075.
124. Erbacher, P.; Zou, S.; Bettinger, T.; Steffan, A.M.; Remy, J.S. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm. Res., 1998, 15 (9), 1332.
125. Roy, K.; Mao, H.Q.; Huang, S.K.; Leong, K.W. Oral gene delivery with chitosan - DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med., 1999, 5 (4), 387.
126. Kumar, M.; Behera, A.K.; Lockey, R.F.; Zhang, J.; Bhullar, G.; De La Cruz, C.P.; Chen, L.C.; Leong, K.W.; Huang, S.K.; Mohapatra, S.S. Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. Hum. Gene Ther., 2002, 13 (12), 1415.
127. Iqbal, M.; Lin, W.; Jabbal-Gill, I.; Davis, S.S.; Steward, M.W.; Illum, L. Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice. Vaccine, 2003, 21 (13), 1478.
128. Koping-Hoggard, M.; Varum, K.M.; Issa, M.; Danielsen, S.; Christensen, B.E.; Stokke, B.T.; Artursson, P. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther., 2004, 11 (19), 1441.
129. Liu, W.G.; Zhang, X.; Sun, S.J.; Sun, G.J.; Yao, K.D.; Liang, D.C.; Guo, G.; Zhang, J.Y. N-alkylated chitosan as a potential nonviral vector for gene transfection. Bioconjug. Chem., 2003, 14 (4), 782.
130. Ishii, T.; Okahata, Y.; Sato, T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim. Biophys. Acta, 2001, 1514 (1), 51.
131. Schatzlein, A.G. Targeting of Synthetic Gene Delivery Systems. J. Biomed. Biotechnol., 2003, 2003 (2), 149.
132. Brown, M.D.; Schatzlein, A.G.; Uchegbu, I.F. Gene delivery with synthetic (non viral) carriers. Int. J. Pharm., 2001, 229 (1-2), 1.
133. Han, S.; Mahato, R.I.; Sung, Y.K.; Kim, S.W. Development of biomaterials for gene therapy. Mol. Ther., 2000, 2 (4), 302.
134. Weiss, S.I.; Sieverling, N.; Niclasen, M.; Maucksch, C.; Thunemann, A.F.; Mohwald, H.; Reinhardt, D.; Rosenecker, J.; Rudolph, C. Uronic acids functionalized polyethyleneimine (PEI)-polyethyleneglycol (PEG)-graft-copolymers as novel synthetic gene carriers. Biomaterials, 2006, 27 (10), 2302.
135. Abdallah, B.; Hassan, A.; Benoist, C.; Goula, D.; Behr, J.P.; Demeneix, B.A. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum. Gene Ther., 1996, 7 (16), 1947.
136. Goula, D.; Remy, J.S.; Erbacher, P.; Wasowicz, M.; Levi, G.; Abdallah, B.; Demeneix, B.A. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther., 1998, 5 (5), 712.
137. Lemkine, G.F.; Goula, D.; Becker, N.; Paleari, L.; Levi, G.; Demeneix, B.A. Optimisation of polyethylenimine-based gene delivery to mouse brain. J. Drug Target., 1999, 7 (4), 305.
138. Boletta, A.; Benigni, A.; Lutz, J.; Remuzzi, G.; Soria, M.R.; Monaco, L. Nonviral gene delivery to the rat kidney with polyethylenimine. Hum. Gene Ther., 1997, 8 (10), 1243.
139. Ferrari, S.; Moro, E.; Pettenazzo, A.; Behr, J.P.; Zacchello, F.; Scarpa, M. ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Ther., 1997, 4 (10), 1100.
140. Pack, D.W.; Hoffman, A.S.; Pun, S.; Stayton, P.S. Design and development of polymers for gene delivery. Nat. Rev. Drug Discov., 2005, 4 (7), 581.
141. Nishikawa, M.; Takakura, Y.; Hashida, M. Pharmacokinetics of plasmid DNA-based non-viral gene medicine. Adv. Genet., 2005, 53, 47.
142. Azzam, T.; Domb, A.J. Current developments in gene transfection agents. Curr Drug Deliv, 2004, 1 (2), 165.
143. Li, S.; Ma, Z. Nonviral gene therapy. Curr. Gene Ther., 2001, 1 (2), 201.
144. Olivares, E.C.; Calos, M.P. Phage φ integrases-mediated situ-specific integration for gene therapy. Gene Ther. Reg., 2003, 2 (2), 103.
145. Ivics, Z. Transposons for Gene Therapy. Curr. Gene Ther., 2006, 6 (5), 593.
146. Kumar, M.N.; Kumar, N. Polymeric controlled drug-delivery systems: perspective issues and opportunities. Drug Dev. Ind. Pharm., 2001, 27 (1), 1.
147. Shea, L.D.; Smiley, E.; Bonadio, J.; Mooney, D.J. DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol., 1999, 17 (6), 551.
148. Bala, I.; Hariharan, S.; Kumar, M.N. PLGA nanoparticles in drug delivery: the state of the art. Crit. Rev. Ther. Drug Carrier Syst., 2004, 21 (5), 387.
149. Langer, R. New methods of drug delivery. Science, 1990, 249 (4976), 1527.
150. Levy, R.J.; Goldstein, S.A.; Bonadio, J. Gene Therapy for tissue repair and regeneration. Adv. Drug Deliv. Rev., 1998, 33 (1-2), 53.
151. Labhasetwar, V. Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery. Curr. Opin. Biotechnol., 2005, 16 (6), 674.
152. Bonadio, J. Tissue engineering via local gene delivery: update and future prospects for enhancing the technology. Adv. Drug Deliv. Rev., 2000, 44 (2-3), 185.
153. Richardson, T.P.; Peters, M.C.; Ennett, A.B.; Mooney, D.J. Polymeric system for dual growth factor delivery. Nat. Biotechnol., 2001, 19 (11), 1029.
154. Panyam, J.; Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev., 2003, 55 (3), 329.
155. Hussain, M.; Beale, G.; Hughes, M.; Akhtar, S. Co-delivery of an antisense oligonucleotide and 5-fluorouracil using sustained release poly (lactide-coglycolide) microsphere formulations for potential combination therapy in cancer. Int. J. Pharm., 2002, 234 (1-2), 129.
156. De Rosa, G.; Bochot, A.; Quaglia, F.; Besnard, M.; Fattal, E. A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes. Int. J. Pharm., 2003, 254 (1), 89.
157. Khan, A.; Benboubetra, M.; Sayyed, P.Z.; Ng, K.W.; Fox, S.; Beck, G.; Benter, I.F.; Akhtar, S. Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies. J. Drug Target., 2004, 12 (6), 393.
158. Shive, M.S.; Anderson, J.M. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev., 1997, 28 (1), 5.
159. Sendil Keskin, D.; Hasirci, V. Controlled release of bioactive agents in gene therapy and tissue engineering. Adv. Exp. Med. Biol., 2003, 543, 279.
160. Nishikawa, M.; Huang, L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum. Gene Ther., 2001, 12 (8), 861.
161. Merdan, T.; Kopecek, J.; Kissel, T. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv. Drug Deliv. Rev., 2002, 54 (5), 715.
162. FDA. Guidance for Industry: Guidance for human somatic cell therapy
163. Walter, E.; Moelling, K.; Pavlovic, J.; Merkle, H.P. Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics. J. Control. Release, 1999, 61 (3), 361.
164. Weintraub, H.; Cheng, P.F.; Conrad, K. Expression of transfected DNA depends on DNA topology. Cell, 1986, 46 (1), 115.
165. Thomasin, C.; Corradin, G.; Ying, M.; Merkle, H.P.; Gander, B. Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/ poly(lactide-coglycolide) microspheres: Importance of polymer degradation and antigen release for immune response. J. Control. Release, 1996, 41 (1), 131.
166. Cherng, J.Y.; Schuurmans-Nieuwenbroek, N.M.; Jiskoot, W.; Talsma, H.; Zuidam, N.J.; Hennink, W.E.; Crommelin, D.J. Effect of DNA topology on the transfection efficiency of poly((2-dimethylamino)ethyl methacrylate)-plasmid complexes. J. Control. Release, 1999, 60 (2-3), 343.
167. Diez, S.; Tros de Ilarduya, C. Versatility of biodegradable poly(d,l-lactic-coglycolic acid) microspheres for plasmid DNA delivery. Eur. J. Pharm. Biopharm., 2006, 63 (2), 188.
168. Cohen, H.; Levy, R.J.; Gao, J.; Fishbein, I.; Kousaev, V.; Sosnowski, S.; Slomkowski, S.; Golomb, G. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther., 2000, 7 (22), 1896.
169. Jong, Y.S. Controlled release of plasmid DNA J. Contol. Release, 1997, 47 123.
170. Sano, A.; Maeda, M.; Nagahara, S.; Ochiya, T.; Honma, K.; Itoh, H.; Miyata, T.; Fujioka, K. Atelocollagen for protein and gene delivery. Adv. Drug Deliv. Rev., 2003, 55 (12), 1651.
171. Li, Z.; Ning, W.; Wang, J.; Choi, A.; Lee, P.Y.; Tyagi, P.; Huang, L. Controlled gene delivery system based on thermosensitive biodegradable hydrogel. Pharm. Res., 2003, 20 (6), 884.
172. Hedley, M.L. Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors. Expert Opin. Biol. Ther., 2003, 3 (6), 903.
173. Ochiya, T.; Nagahara, S.; Sano, A.; Itoh, H.; Terada, M. Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines. Curr. Gene Ther., 2001, 1 (1), 31.
174. Jain, R.A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials, 2000, 21 (23), 2475.
175. Eliaz, R.E.; Szoka, F.C., Jr. Robust and prolonged gene expression from injectable polymeric implants. Gene Ther., 2002, 9 (18), 1230.
176. Hatefi, A.; Amsden, B. Biodegradable injectable in situ forming drug delivery systems. J. Control. Release, 2002, 80 (1-3), 9.
177. Ratner, B.D.; Bryant, S.J. Biomaterials: where we have been and where we are going. Annu. Rev. Biomed. Eng., 2004, 6, 41.
178. Dang, J.M.; Leong, K.W. Natural polymers for gene delivery and tissue engineering. Adv. Drug Deliv. Rev., 2006, 58 (4), 487.
179. Pannier, A.K.; Shea, L.D. Controlled release systems for DNA delivery. Mol. Ther., 2004, 10 (1), 19.
180. Chvapil, M. Collagen sponge: theory and practice of medical applications. J. Biomed. Mater. Res., 1977, 11 (5), 721.
181. Hirasawa, T.; Sano, A.; Fujioka, K.; Inoue, K.; Miyata, K.; Minoru; Nakano; Yamashita, K.; Hayakawa, T. Biodegradability of Minipellet a new drug formulation using atelocollagen as a drug carrier material, in rhesus monkey. Biomed. Res., 1997, 18 (2), 149.
182. Patino, M.G.; Neiders, M.E.; Andreana, S.; Noble, B.; Cohen, R.E. Collagen as an implantable material in medicine and dentistry. J. Oral Implantol., 2002, 28 (5), 220.
183. Stenzel, K.H.; Miyata, T.; Rubin, A.L. Collagen as a biomaterial. Annu. Rev. Biophys. Bioeng., 1974, 3 (0), 231.
184. Rao, K.P. Recent developments of collagen-based materials for medical applications and drug delivery systems. J. Biomater. Sci. Polym. Ed., 1995, 7 (7), 623.
185. Matarasso, S.L. The use of injectable collagens for aesthetic rejuvenation. Semin. Cutan. Med. Surg., 2006, 25 (3), 151.
186. Djagny, V.B.; Wang, Z.; Xu, S. Gelatin: a valuable protein for food and pharmaceutical industries: review. Crit. Rev. Food Sci. Nutr., 2001, 41 (6), 481.
187. Young, S.; Wong, M.; Tabata, Y.; Mikos, A.G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J. Control. Release, 2005, 109 (1-3), 256.
188. Kushibiki, T.; Tabata, Y. A new gene delivery system based on controlled release technology. Curr. Drug Deliv., 2004, 1 (2), 153.
189. Kushibiki, T.; Tomoshige, R.; Iwanaga, K.; Kakemi, M.; Tabata, Y. Controlled release of plasmid DNA from hydrogels prepared from gelatin cationized by different amine compounds. J. Control. Release, 2006, 112 (2), 249.
190. Truong-Le, V.L.; Walsh, S.M.; Schweibert, E.; Mao, H.Q.; Guggino, W.B.; August, J.T.; Leong, K.W. Gene transfer by DNA-gelatin nanospheres. Arch. Biochem. Biophys., 1999, 361 (1), 47.
191. Schwick, H.G.; Heide, K. Immunochemistry and immunology of collagen and gelatin. Bibl. Haematol., 1969, 33, 111.
192. Fukunaka, Y.; Iwanaga, K.; Morimoto, K.; Kakemi, M.; Tabata, Y. Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. J. Control. Release, 2002, 80 (1-3), 333.
193. Kushibiki, T.; Tomoshige, R.; Fukunaka, Y.; Kakemi, M.; Tabata, Y. In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents. J. Control. Release, 2003, 90 (2), 207.
194. Ikada, Y.; Tabata, Y. Protein release from gelatin matrices. Adv. Drug Deliv. Rev., 1998, 31 (3), 287.
195. Zwiorek, K.; Kloeckner, J.; Wagner, E.; Coester, C. Gelatin nanoparticles as a new and simple gene delivery system. J. Pharm. Pharm. Sci., 2005, 7 (4), 22.
196. Kasper, F.K.; Kushibiki, T.; Kimura, Y.; Mikos, A.G.; Tabata, Y. In vivo release of plasmid DNA from composites of oligo(poly(ethylene glycol)fumarate) and cationized gelatin microspheres. J. Control Release, 2005, 107 (3), 547.
197. Prestwich, G.D.; Marecek, D.M.; Marecek, J.F.; Vercruysee, K.P.; Ziebell, M.R. In The chemistry, biology, and medical applications of hyaluronan and its derivatives; Laurent, T.C., Ed.; Portland Press: London, 1998, Vol. 72, pp. 43.
198. Fraser, J.R.E.; Brown, T.J.; Laurent, T.C. In The chemistry, biology, and medical applications of hyaluronan and its derivatives; Laurent, T.C., Ed.; Portland Press: London, 1998, Vol. 72, pp. 85.
199. Scott, J.E. Extracellular matrix, supramolecular organisation and shape. J. Anat., 1995, 187 (Pt 2), 259.
200. Toole, B.P. Hyaluronan in morphogenesis. J. Intern. Med., 1997, 242 (1), 35.
201. Balazs, E.A.; Denlinger, J.L. Clinical uses of hyaluronan. Ciba Found. Symp., 1989, 143, 265; discussion 275, 281.
202. Liao, Y.H.; Jones, S.A.; Forbes, B.; Martin, G.P.; Brown, M.B. Hyaluronan: pharmaceutical characterization and drug delivery. Drug Deliv., 2005, 12 (6), 327.
203. Goa, K.L.; Benfield, P. Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs, 1994, 47 (3), 536.
204. Davidson, J.M.; Nanney, L.B.; Broadley, K.N.; Whitsett, J.S.; Aquino, A.M.; Beccaro, M.; Rastrelli, A. Hyaluronate derivatives and their application to wound healing: preliminary observations. Clin. Mater., 1991, 8 (1-2), 171.
205. Juhlin, L. Hyaluronan in skin. J. Intern. Med., 1997, 242 (1), 61.
206. Luo, Y.; Kirker, K.R.; Prestwich, G.D. In Methods of tissue engineering; Atala, A.; Lanza, R.P., Eds.; Academic Press: New York, 2001, Vol. 539.
207. Vercruysse, K.P.; Marecak, D.M.; Marecek, J.F.; Prestwich, G.D. Synthesis and in vitro degradation of new polyvalent hydrazide cross-linked hydrogels of hyaluronic acid. Bioconjug. Chem., 1997, 8 (5), 686.
208. Yun, Y.H.; Goetz, D.J.; Yellen, P.; Chen, W. Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials, 2004, 25 (1), 147.
209. Segura, T.; Chung, P.H.; Shea, L.D. DNA delivery from hyaluronic acid-collagen hydrogels via a substrate-mediated approach. Biomaterials, 2005, 26 (13), 1575.
210. Kim, A.; Checkla, D.M.; Dehazya, P.; Chen, W. Characterization of DNA-hyaluronan matrix for sustained gene transfer. J. Control. Release, 2003, 90 (1), 81.
211. Cappello, J.; Crissman, J.W.; Crissman, M.; Ferrari, F.A.; Textor, G.; Wallis, O.; Whitledge, J.R.; Zhou, X.; Burman, D.; Aukerman, L.; Stedronsky, E.R. In-situ self-assembling protein polymer gel systems for administration, delivery, and release of drugs. J. Control. Release, 1998, 53 (1-3), 105.
212. Cappello, J.; Crissman, J.; Dorman, M.; Mikolajczak, M.; Textor, G.; Marquet, M.; Ferrari, F. Genetic engineering of structural protein polymers. Biotechnol. Prog., 1990, 6 (3), 198.
213. Megeed, Z.; Cappello, J.; Ghandehari, H. Genetically engineered silk-elastinlike protein polymers for controlled drug delivery. Adv. Drug Deliv. Rev., 2002, 54 (8), 1075.
214. Megeed, Z.; Cappello, J.; Ghandehari, H. Controlled release of plasmid DNA from a genetically engineered silk-elastinlike hydrogel. Pharm. Res., 2002, 19 (7), 954.
215. Langer, R.; Folkman, J. Polymers for the sustained release of proteins and other macromolecules. Nature, 1976, 263 (5580), 797.
216. Luo, D.; Woodrow-Mumford, K.; Belcheva, N.; Saltzman, W.M. Controlled DNA delivery systems. Pharm. Res., 1999, 16 (8), 1300.
217. Shen, H.; Goldberg, E.; Saltzman, W.M. Gene expression and mucosal immune responses after vaginal DNA immunization in mice using a controlled delivery matrix. J. Control. Release, 2003, 86 (2-3), 339.
218. Wu, X.S. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: Part III. Drug delivery application. Artif. Cells Blood Substit. Immobil. Biotechnol., 2004, 32 (4), 575.
219. Wu, X.S.; Wang, N. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: biodegradation. J. Biomater. Sci. Polym. Ed., 2001, 12 (1), 21.
220. Frazza, E.J.; Schmitt, E.E. A new absorbable suture. J. Biomed. Mater. Res., 1971, 5 (2), 43.
221. Mooney, D.J.; Sano, K.; Kaufmann, P.M.; Majahod, K.; Schloo, B.; Vacanti, J.P.; Langer, R. Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J. Biomed. Mater. Res., 1997, 37 (3), 413.
222. Gopferich, A. Mechanisms of polymer degradation and erosion. Biomaterials, 1996, 17 (2), 103.
223. Wu, S.W. In Encyclopedic handbook of biomaterials and bioengineering, Part A: Materials; Wise, D.L.; Trantolot, D.J.; Altobelli, D.E.; Yaszemski, M.J.; Gresser, J.D.; Schwartz, E.R., Ed.; Marcel Dekker: New York, 1995, Vol. 2, pp. 1015.
224. Vert, M.; Mauduit, J.; Li, S. Biodegradation of PLA/GA polymers: increasing complexity. Biomaterials, 1994, 15 (15), 1209.
225. Grizzi, I.; Garreau, H.; Li, S.; Vert, M. Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. Biomaterials, 1995, 16 (4), 305.
226. Landes, C.A.; Ballon, A.; Roth, C. In-patient versus in vitro degradation of P(L/DL)LA and PLGA. J. Biomed. Mater. Res. Part B Appl. Biomater., 2006, 76 (2), 403.
227. Capan, Y.; Woo, B.H.; Gebrekidan, S.; Ahmed, S.; DeLuca, P.P. Influence of formulation parameters on the characteristics of poly(D, L-lactide-coglycolide) microspheres containing poly(L-lysine) complexed plasmid DNA. J. Control. Release, 1999, 60 (2-3), 279.
228. Prabha, S.; Labhasetwar, V. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression. Pharm. Res., 2004, 21 (2), 354.
229. Ravi Kumar, M.; Hellermann, G.; Lockey, R.F.; Mohapatra, S.S. Nanoparticle-mediated gene delivery: state of the art. Expert Opin. Biol. Ther., 2004, 4 (8), 1213.
230. Bauer, K.H.; Frömming, K.-H.; Fürer, C.; Egermann, H.; Garf, E.; Leuenberger, H. Lehrbuch der Pharmazeutischen Technologie, Wissenschaftliche Verlagsgesellschaft: Stuttgart, 2002.
231. Truong-Le, V.L., Thomas August, and Kam W. Leong Controlled Gene Delivery by DNA-Gelatin Nanospheres. Hum. Gene Ther., 1998, 9 1709.
232. Leong, K.W.; Mao, H.Q.; Truong-Le, V.L.; Roy, K.; Walsh, S.M.; August, J.T. DNA-polycation nanospheres as non-viral gene delivery vehicles. J. Control. Release, 1998, 53 (1-3), 183.
233. Cohen-Sacks, H.; Elazar, V.; Gao, J.; Golomb, A.; Adwan, H.; Korchov, N.; Levy, R.J.; Berger, M.R.; Golomb, G. Delivery and expression of pDNA embedded in collagen matrices. J. Control. Release, 2004, 95 (2), 309.
234. Wang, J.; Lee, I.L.; Lim, W.S.; Chia, S.M.; Yu, H.; Leong, K.W.; Mao, H.Q. Evaluation of collagen and methylated collagen as gene carriers. Int. J. Pharm., 2004, 279 (1-2), 115.
235. Chia, S.M.; Leong, K.W.; Li, J.; Xu, X.; Zeng, K.; Er, P.N.; Gao, S.; Yu, H. Hepatocyte encapsulation for enhanced cellular functions. Tissue Eng., 2000, 6 (5), 481.
236. Ruponen, M.; Ronkko, S.; Honkakoski, P.; Pelkonen, J.; Tammi, M.; Urtti, A. Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes. J. Biol. Chem., 2001, 276 (36), 33875.
237. Thakor, D.; Spigelman, I.; Tabata, Y.; Nishimura, I. Subcutaneous peripheral injection of cationized gelatin/DNA polyplexes as a platform for non-viral gene transfer to sensory neurons. Mol. Ther., 2007, 15 (12), 2124.
238. Coester, C.J.; Langer, K.; van Briesen, H.; Kreuter, J. Gelatin nanoparticles by two step desolvation - a new preparation method, surface modifications and cell uptake. J. Microencapsul., 2000, 17 (2), 187.
239. Lim, S.T.; Martin, G.P.; Berry, D.J.; Brown, M.B. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J. Control. Release, 2000, 66 (2-3), 281.
240. Labhasetwar, V.; Bonadio, J.; Goldstein, S.A.; Levy, R.J. Gene transfection using biodegradable nanospheres: results in tissue culture and rat osteotomy model. Colloids Surf. B Biointerfaces, 1999, 16 (1-4), 281.
241. Perez, C.; Sanchez, A.; Putnam, D.; Ting, D.; Langer, R.; Alonso, M.J. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J. Control. Release, 2001, 75 (1-2), 211.
242. Moghimi, S.M.; Hunter, A.C.; Murray, J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev., 2001, 53(2), 283.
243. Redhead, H.M.; Davis, S.S.; Illum, L. Drug delivery in poly(lactide-coglycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J. Control. Release, 2001, 70(3), 353.
244. Desai, M.P.; Labhasetwar, V.; Walter, E.; Levy, R.J.; Amidon, G.L. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res., 1997, 14 (11), 1568.
245. Desai, M.P.; Labhasetwar, V.; Amidon, G.L.; Levy, R.J. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm. Res., 1996, 13 (12), 1838.
246. Prabha, S.; Zhou, W.Z.; Panyam, J.; Labhasetwar, V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int. J. Pharm., 2002, 244 (1-2), 105.
247. Panyam, J.; Labhasetwar, V. Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm. Res., 2003, 20 (2), 212.
248. Zauner, W.; Farrow, N.A.; Haines, A.M. In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. J. Control. Release, 2001, 71 (1), 39.
249. Edwards, D.A.; Ben-Jebria, A.; Langer, R. Recent advances in pulmonary drug delivery using large, porous inhaled particles. J. Appl. Physiol., 1998, 85 (2), 379.
250. Davda, J.; Labhasetwar, V. Characterization of nanoparticle uptake by endothelial cells. Int. J. Pharm., 2002, 233 (1-2), 51.
251. Wattiaux, R.; Laurent, N.; Wattiaux-De Coninck, S.; Jadot, M. Endosomes, lysosomes: their implication in gene transfer. Adv. Drug Deliv. Rev., 2000, 41 (2), 201.
252. Panyam, J.; Zhou, W.Z.; Prabha, S.; Sahoo, S.K.; Labhasetwar, V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J., 2002, 16 (10), 1217.
253. Stolnik, S.; Garnett, M.C.; Davies, M.C.; Illum, L.; Bousta, M.; Vert, M.; Davis, S.S. The colloidal properties of surfactant-free biodegradable nanopsheres from poly(beta-malic acid-co-benzyl malate)s and poly(lactide acid-co-glycolide). Colloids Surf. A: Physicochem. Eng. Aspects, 1995, 97, 235.
254. Makino, K.; Ohshima, H.; Kondo, T. Transfer of protons from bulk solution to the surface of poly(L-lactide) microcapsules. J. Microencapsul., 1986, 3 (3), 195.
255. Tomoda, H.; Kishimoto, Y.; Lee, Y.C. Temperature effect on endocytosis and exocytosis by rabbit alveolar macrophages. J. Biol. Chem., 1989, 264 (26), 15445.
256. Fu, K.; Pack, D.W.; Klibanov, A.M.; Langer, R. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm. Res., 2000, 17 (1), 100.
257. Tinsley-Bown, A.M.; Fretwell, R.; Dowsett, A.B.; Davis, S.L.; Farrar, G.H. Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. J. Control. Release, 2000, 66 (2-3), 229.
258. Shendora, A.; Burke, T.G.; Schwendeman, S.P. Evidence for acidic microclimate in PLGA microspheres. Proc. Int. Symp. Control. Release Bioact. Mater., 1998, 25, 265.
259. Csaba, N.; Caamano, P.; Sanchez, A.; Dominguez, F.; Alonso, M.J. PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery. Biomacromolecules, 2005, 6 (1), 271.
260. Ando, S.; Putnam, D.; Pack, D.W.; Langer, R. PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J. Pharm. Sci., 1999, 88 (1), 126.
261. Wang, D.; Robinson, D.R.; Kwon, G.S.; Samuel, J. Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J. Control. Release, 1999, 57 (1), 9.
262. Rizkalla, N.; Range, C.; Lacasse, F.X.; Hildgen, P. Effect of various formulation parameters on the properties of polymeric nanoparticles prepared by multiple emulsion method. J. Microencapsul., 2006, 23 (1), 39.
263. Sahoo, S.K.; Panyam, J.; Prabha, S.; Labhasetwar, V. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Control. Release, 2002, 82 (1), 105.
264. Ravi Kumar, M.N.; Bakowsky, U.; Lehr, C.M. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials, 2004, 25 (10), 1771.
265. Mumper, R.J.; Duguid, J.G.; Anwer, K.; Barron, M.K.; Nitta, H.; Rolland, A.P. Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle. Pharm. Res., 1996, 13 (5), 701.
266. Capan, Y.; Woo, B.H.; Gebrekidan, S.; Ahmed, S.; DeLuca, P.P. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA. Pharm. Res., 1999, 16 (4), 509.
267. Bivas-Benita, M.; Romeijn, S.; Junginger, H.E.; Borchard, G. PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium. Eur. J. Pharm. Biopharm., 2004, 58 (1), 1-6.
268. Kim, I.S.; Lee, S.K.; Park, Y.M.; Lee, Y.B.; Shin, S.C.; Lee, K.C.; Oh, I.J. Physicochemical characterization of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier. Int. J. Pharm., 2005, 298 (1), 255.
269. Kumar, M.N.; Mohapatra, S.S.; Kong, X.; Jena, P.K.; Bakowsky, U.; Lehr, C.M. Cationic poly(lactide-co-glycolide) nanoparticles as efficient in vivo gene transfection agents. J. Nanosci. Nanotechnol., 2004, 4 (8), 990.
270. Singh, M.; Briones, M.; Ott, G.; O'Hagan, D. Cationic microparticles: A potent delivery system for DNA vaccines. Proc. Natl. Acad. Sci. USA, 2000, 97 (2), 811.
271. Munier, S.; Messai, I.; Delair, T.; Verrier, B.; Ataman-Onal, Y. Cationic PLA nanoparticles for DNA delivery: comparison of three surface polycations for DNA binding, protection and transfection properties. Colloids Surf. B Biointerfaces, 2005, 43 (3-4), 163.
272. Oster, C.G.; Kim, N.; Grode, L.; Barbu-Tudoran, L.; Schaper, A.K.; Kaufmann, S.H.; Kissel, T. Cationic microparticles consisting of poly(lactide-coglycolide) and polyethylenimine as carriers systems for parental DNA vaccination. J. Control. Release, 2005, 104 (2), 359.
273. Singh, M.; Kazzaz, J.; Ugozzoli, M.; Chesko, J.; O'Hagan, D.T. Charged polylactide co-glycolide microparticles as antigen delivery systems. Expert Opin. Biol. Ther., 2004, 4 (4), 483.
274. Denis-Mize, K.S.; Dupuis, M.; Singh, M.; Woo, C.; Ugozzoli, M.; O'Hagan, D.T.; Donnelly, J.J., 3rd; Ott, G.; McDonald, D.M. Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles. Cell Immunol., 2003, 225 (1), 12.
275. Denis-Mize, K.S.; Dupuis, M.; MacKichan, M.L.; Singh, M.; Doe, B.; O'Hagan, D.; Ulmer, J.B.; Donnelly, J.J.; McDonald, D.M.; Ott, G. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Ther., 2000, 7 (24), 2105.
276. Singh, M.; Ott, G.; Kazzaz, J.; Ugozzoli, M.; Briones, M.; Donnelly, J.; O'Hagan, D.T. Cationic microparticles are an effective delivery system for immune stimulatory cpG DNA. Pharm. Res., 2001, 18 (10), 1476.
277. Li, Z.; Huang, L. Sustained delivery and expression of plasmid DNA based on biodegradable polyester, poly(D,L-lactide-co-4-hydroxy-L-proline). J. Control. Release, 2004, 98 (3), 437.
278. Ochiya, T.; Takahama, Y.; Nagahara, S.; Sumita, Y.; Hisada, A.; Itoh, H.; Nagai, Y.; Terada, M. New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet. Nat. Med., 1999, 5 (6), 707.
279. Sano, A.; Hojo, T.; Maeda, M.; Fujioka, K. Protein release from collagen matrices. Adv. Drug Deliv. Rev., 1998, 31 (3), 247.
280. Higaki, M.; Azechi, Y.; Takase, T.; Igarashi, R.; Nagahara, S.; Sano, A.; Fujioka, K.; Nakagawa, N.; Aizawa, C.; Mizushima, Y. Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoid. Vaccine, 2001, 19 (23), 3091.
281. Clark, K.R.; Johnson, P.R. Gene delivery of vaccines for infectious disease. Curr. Opin. Mol. Ther., 2001, 3 (4), 375.
282. Putnam, A.J.; Mooney, D.J. Tissue engineering using synthetic extracellular matrices. Nat. Med., 1996, 2 (7), 824.
283. Ahsan, T.; Nerem, R.M. Bioengineered tissues: the science, the technology, and the industry. Orthod. Craniofac. Res., 2005, 8 (3), 134.
284. Portner, R.; Nagel-Heyer, S.; Goepfert, C.; Adamietz, P.; Meenen, N.M. Bioreactor design for tissue engineering. J. Biosci. Bioeng., 2005, 100 (3), 235.
285. Jang, J.H.; Houchin, T.L.; Shea, L.D. Gene delivery from polymer scaffolds for tissue engineering. Expert Rev. Med. Devices, 2004, 1 (1), 127.
286. Tseng, W.C.; Haselton, F.R.; Giorgio, T.D. Mitosis enhances transgene expression of plasmid delivered by cationic liposomes. Biochim. Biophys. Acta, 1999, 1445 (1), 53.
287. Bonadio, J. Tissue engineering via local gene delivery. J. Mol. Med., 2000, 78 (6), 303.
288. Ono, I.; Yamashita, T.; Jin, H.Y.; Ito, Y.; Hamada, H.; Akasaka, Y.; Nakasu, M.; Ogawa, T.; Jimbow, K. Combination of porous hydroxyapatite and cationic liposomes as a vector for BMP-2 gene therapy. Biomaterials, 2004, 25 (19), 4709.
289. Murphy, W.L.; Mooney, D.J. Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices. J. Periodontal Res., 1999, 34 (7), 413.
290. Bottaro, D.P.; Liebmann-Vinson, A.; Heidaran, M.A. Molecular signaling in bioengineered tissue microenvironments. Ann. N. Y. Acad. Sci., 2002, 961 143.
291. Kim, B.S.; Mooney, D.J. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol., 1998, 16 (5), 224.
292. Jang, J.H.; Rives, C.B.; Shea, L.D. Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection. Mol. Ther., 2005, 12 (3), 475.
293. Bonadio, J.; Smiley, E.; Patil, P.; Goldstein, S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat. Med., 1999, 5 (7), 753.
294. Pascher, A.; Palmer, G.D.; Steinert, A.; Oligino, T.; Gouze, E.; Gouze, J.N.; Betz, O.; Spector, M.; Robbins, P.D.; Evans, C.H.; Ghivizzani, S.C. Gene delivery to cartilage defects using coagulated bone marrow aspirate. Gene Ther., 2004, 11 (2), 133.
295. Tyrone, J.W.; Mogford, J.E.; Chandler, L.A.; Ma, C.; Xia, Y.; Pierce, G.F.; Mustoe, T.A. Collagen-embedded platelet-derived growth factor DNA plasmid promotes wound healing in a dermal ulcer model. J. Surg. Res., 2000, 93 (2), 230.
296. Jang, J.H.; Bengali, Z.; Houchin, T.L.; Shea, L.D. Surface adsorption of DNA to tissue engineering scaffolds for efficient gene delivery. J. Biomed. Mater. Res. A, 2006, 77 (1), 50.
297. Segura, T.; Shea, L.D. Surface-tethered DNA complexes for enhanced gene delivery. Bioconjug. Chem., 2002, 13 (3), 621.
298. Saltzman, W.M.; Olbricht, W.L. Building drug delivery into tissue engineering. Nat. Rev. Drug Discov., 2002, 1 (3), 177.
299. Bengali, Z.; Pannier, A.K.; Segura, T.; Anderson, B.C.; Jang, J.H.; Mustoe, T.A.; Shea, L.D. Gene delivery through cell culture substrate adsorbed DNA complexes. Biotechnol. Bioeng., 2005, 90 (3), 290.
300. Bielinska, A.U.; Yen, A.; Wu, H.L.; Zahos, K.M.; Sun, R.; Weiner, N.D.; Baker, J.R., Jr.; Roessler, B.J. Application of membrane-based dendrimer/ DNA complexes for solid phase transfection in vitro and in vivo. Biomaterials, 2000, 21 (9), 877.
301. Scherer, F.; Schillinger, U.; Putz, U.; Stemberger, A.; Plank, C. Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo. J. Gene Med., 2002, 4 (6), 634.
302. Finsinger, D.; Remy, J.S.; Erbacher, P.; Koch, C.; Plank, C. Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery. Gene Ther., 2000, 7 (14), 1183.
303. Kim, A.P.; Yellen, P.; Yun, Y.H.; Azeloglu, E.; Chen, W. Delivery of a vector encoding mouse hyaluronan synthase 2 via a crosslinked hyaluronan film. Biomaterials, 2005, 26 (13), 1585.
304. Segura, T.; Volk, M.J.; Shea, L.D. Substrate-mediated DNA delivery: role of the cationic polymer structure and extent of modification. J. Control. Release, 2003, 93 (1), 69.
305. Huang, Y.C.; Riddle, K.; Rice, K.G.; Mooney, D.J. Long-term in vivo gene expression via delivery of PEI-DNA condensates from porous polymer scaffolds. Hum. Gene Ther., 2005, 16 (5), 609.
306. Jang, J.H.; Shea, L.D. Controllable delivery of non-viral DNA from porous scaffolds. J. Control. Release, 2003, 86 (1), 157.
307. Richardson, T.P.; Murphy, W.L.; Mooney, D.J. Polymeric delivery of proteins and plasmid DNA for tissue engineering and gene therapy. Crit. Rev. Eukaryot. Gene Expr., 2001, 11 (1-3), 47.
308. Harris, L.D.; Kim, B.S.; Mooney, D.J. Open pore biodegradable matrices formed with gas foaming. J. Biomed. Mater. Res., 1998, 42 (3), 396.
309. Packhaeuser, C.B.; Schnieders, J.; Oster, C.G.; Kissel, T. In situ forming parenteral drug delivery systems: an overview. Eur. J. Pharm. Biopharm., 2004, 58 (2), 445.
310. Chandrashekar; Bhagya, L.; Zhou; Mingxing; Jarr; M., E.; Dunn; Richard, L. U.S. Patent 6,630,155, 2003.
311. Dunn, R.L. The Artigel Drug delivery System Drugs and the Pharmaceutical Sciences, 2003, 126, 647.
312. Eliaz, R.E.; Kost, J. Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins. J. Biomed. Mater. Res., 2000, 50 (3), 388.
313. Eliaz, R.E.; Wallach, D.; Kost, J. Delivery of soluble tumor necrosis factor receptor from in-situ forming PLGA implants: in-vivo. Pharm. Res., 2000, 17 (12), 1546.
314. Chandrashekar, G.; Udupa, N. Biodegradable injectable implant systems for long term drug delivery using poly (lactic-co-glycolic) acid copolymers. J. Pharm. Pharmacol., 1996, 48 (7), 669.
315. Dunn, R.L.; Yewey, G.L.; Futjita, S.M.; Josephs, K.R.; Whitman, S.L.; Southard, G.L. Sustained release of cisplatin in dogs from injectable implant delivery system. J. Bioact. Compt. Polym., 1996, 11 (4), 286.
316. Eliaz, R.E. U.S. Patent 6,206,920, 2001.
317. Dunn, R.L.; Tripton, A.P. U.S. Patent 5,702,716, 1997.
318. Dunn, R.L.; English, J.P.; Cowsar, D.R.; Vanderbilt, D.P. U.S. Patent 4,938,763, 1990.
319. Brodbeck, K.J.; DesNoyer, J.R.; McHugh, A.J. Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer. J. Control. Release, 1999, 62 (3), 333.
320. Graham, P.D.; Brodbeck, K.J.; McHugh, A.J. Phase inversion dynamics of PLGA solutions related to drug delivery. J. Control. Release, 1999, 58 (2), 233.
321. Lambert, W.J.; Peck, K.D. Development of an in situ forming biodegradable poly-lactide-co-glycolide system for the controlled release of proteins. J. Control. Release, 1995, 33 (1), 189.
322. Matschke, C. Ph.D.thesis, University of Basel: Basel, 2002.
323. Freid, I.; Traitel, T.; Goldbart, R.; Shmilowitz, D.; Wolfson, M.; Kost, J. Cancer Gene Therapy Using pH-Sensitive Polyplexes Released From an Injectable PLGA Implant. 33rd Annual Meeting of the Controlled Release Society Vienna, 2005, 598.
324. Joshi, R.; Arora, V.; Desjardins, J.P.; Robinson, D.; Himmelstein, K.J.; Iversen, P.L. In vivo properties of an in situ forming gel for parenteral delivery of macromolecular drugs. Pharm. Res., 1998, 15 (8), 1189.
325. Haglund, B.O.; Joshi, R.; Himmelstein, K.J. An in situ gelling system for parenteral delivery. J. Control. Release, 1996, 41 (3), 229.
326. Ismail, F.A.; Napaporn, J.; Hughes, J.A.; Brazeau, G.A. In situ gel formulations for gene delivery: release and myotoxicity studies. Pharm. Dev. Technol., 2000, 5 (3), 391.
327. Kurisawa, M.; Yokoyama, M.; Okano, T. Gene expression control by temperature with thermo-responsive polymeric gene carriers. J. Control. Release, 2000, 69 (1), 127.
328. Rathi, R.C.; Zentner, G.M.; Jeong, B. U.S. Patent 6,201,072, 2001.
329. Cha, Y.; Choi, Y.K.; Bae, Y.H. PCT Int. Appl. 9,715,287, 1997.
330. Megeed, Z.; Haider, M.; Li, D.; O'Malley, B.W., Jr.; Cappello, J.; Ghandehari, H. In vitro and in vivo evaluation of recombinant silk-elastinlike hydrogels for cancer gene therapy. J. Control. Release, 2004, 94 (2-3), 433.
331. Lin, H.R.; Sung, K.C. Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J. Control. Release, 2000, 69 (3), 379.
332. Kumar, S.; Himmelstein, K.J. Modification of in situ gelling behavior of carbopol solutions by hydroxypropyl methylcellulose. J. Pharm. Sci., 1995, 84 (3), 344.
333. Rosenberg, S.A.; Aebersold, P.; Cornetta, K.; Kasid, A.; Morgan, R.A.; Moen, R.; Karson, E.M.; Lotze, M.T.; Yang, J.C.; Topalian, S.L.; et al. Gene transfer into humans - immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med., 1990, 323 (9), 570.
334. Dull, T.; Zufferey, R.; Kelly, M.; Mandel, R.J.; Nguyen, M.; Trono, D.; Naldini, L. A third-generation lentivirus vector with a conditional packaging system. J. Virol., 1998, 72 (11), 8463.
335. Einfeld, D.A.; Roelvink, P.W. Advances towards targetable adenovirus vectors for gene therapy. Curr. Opin. Mol. Ther., 2002, 4 (5), 444.
336. Jiao, S.; Cheng, L.; Wolff, J.A.; Yang, N.S. Particle bombardment-mediated gene transfer and expression in rat brain tissues. Biotechnology (N Y), 1993, 11 (4), 497.
337. Tenenbaum, L.; Lehtonen, E.; Monahan, P.E. Evaluation of risks related to the use of adeno-associated virus-based vectors. Curr. Gene Ther., 2003, 3 (6), 545.
338. Latchman, D.S. Gene delivery and gene therapy with herpes simplex virus-based vectors. Gene, 2001, 264 (1), 1.
339. Hui, S.W.; Langner, M.; Zhao, Y.L.; Ross, P.; Hurley, E.; Chan, K. The role of helper lipids in cationic liposome-mediated gene transfer. Biophys. J., 1996, 71 (2), 590.
340. Co, D.O.; Borowski, A.H.; Leung, J.D.; van der Kaa, J.; Hengst, S.; Platenburg, G.J.; Pieper, F.R.; Perez, C.F.; Jirik, F.R.; Drayer, J.I. Generation of transgenic mice and germline transmission of a mammalian artificial chromosome introduced into embryos by pronuclear microinjection. Chromosome Res., 2000, 8 (3), 183.
341. Gersting, S.W.; Schillinger, U.; Lausier, J.; Nicklaus, P.; Rudolph, C.; Plank, C.; Reinhardt, D.; Rosenecker, J. Gene delivery to respiratory epithelial cells by magnetofection. J. Gene Med., 2004, 6 (8), 913.
342. Wells, D.J. Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther., 2004, 11 (18), 1363.
343. Dileo, J.; Miller, T.E., Jr.; Chesnoy, S.; Huang, L. Gene transfer to subdermal tissues via a new gene gun design. Hum. Gene Ther., 2003, 14 (1), 79.
344. Yew, N.S.; Zhao, H.; Przybylska, M.; Wu, I.H.; Tousignant, J.D.; Scheule, R.K.; Cheng, S.H. CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo. Mol. Ther., 2002, 5 (6), 731.
345. Anderson, D.G.; Peng, W.; Akinc, A.; Hossain, N.; Kohn, A.; Padera, R.; Langer, R.; Sawicki, J.A. A polymer library approach to suicide gene therapy for cancer. Proc. Natl. Acad. Sci. USA, 2004, 101 (45), 16028.
346. Duncan, R.; Izzo, L. Dendrimer biocompatibility and toxicity. Adv. Drug Deliv. Rev., 2005, 57 (15), 2215.
347. Gebhart, C.L.; Kabanov, A.V. Evaluation of polyplexes as gene transfer agents. J. Control. Release, 2001, 73 (2-3), 401.
348. Dufes, C.; Uchegbu, I.F.; Schatzlein, A.G. Dendrimers in gene delivery. Adv. Drug Deliv. Rev., 2005, 57 (15), 2177.
349. Hirano, S.; Seino, H.; Akiyama, Y.; Nonaka, I. Bio-compatibility of chitosan by oral and intravenous administrations. Polym. Mater. Sci. Eng., 1988, 59, 897.
350. Kim, T.H.; Ihm, J.E.; Choi, Y.J.; Nah, J.W.; Cho, C.S. Efficient gene delivery by urocanic acid-modified chitosan. J. Control. Release, 2003, 93 (3), 389.
351. Gottschalk, S.; Cristiano, R.J.; Smith, L.C.; Woo, S.L. Folate receptor mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression. Gene Ther., 1994, 1 (3), 185.
352. Guo, W.; Lee, R.L. Receptor-targeted gene delivery via folate-conjugated polyethylenimine. AAPS Pharm Sci., 1999, 1 (4), E19.
353. Cotten, M.; Langle-Rouault, F.; Kirlappos, H.; Wagner, E.; Mechtler, K.; Zenke, M.; Beug, H.; Birnstiel, M.L. Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. Proc. Natl. Acad. Sci. USA, 1990, 87 (11), 4033.
354. Kircheis, R.; Kichler, A.; Wallner, G.; Kursa, M.; Ogris, M.; Felzmann,
355. Dufes, C.; Muller, J.M.; Couet, W.; Olivier, J.C.; Uchegbu, I.F.; Schatzlein, A.G. Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles. Pharm. Res., 2004, 21 (1), 101.
356. Kunath, K.; Merdan, T.; Hegener, O.; Haberlein, H.; Kissel, T. Integrin targeting using RGD-PEI conjugates for in vitro gene transfer. J. Gene Med., 2003, 5 (7), 588.
357. Erbacher, P.; Remy, J.S.; Behr, J.P. Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther., 1999, 6 (1), 138.
358. Blessing, T.; Kursa, M.; Holzhauser, R.; Kircheis, R.; Wagner, E. Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjug. Chem., 2001, 12 (4), 529.
359. Xu, B.; Wiehle, S.; Roth, J.A.; Cristiano, R.J. The contribution of poly-L-lysine, epidermal growth factor and streptavidin to EGF/PLL/DNA polyplex formation. Gene Ther., 1998, 5 (9), 1235.
360. Zanta, M.A.; Boussif, O.; Adib, A.; Behr, J.P. In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. Bioconjug. Chem., 1997, 8 (6), 839.
361. Bettinger, T.; Remy, J.S.; Erbacher, P. Size reduction of galactosylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes. Bioconjug. Chem., 1999, 10 (4), 558.
362. Diebold, S.S.; Lehrmann, H.; Kursa, M.; Wagner, E.; Cotten, M.; Zenke, M. Efficient gene delivery into human dendritic cells by adenovirus polyethylenimine and mannose polyethylenimine transfection. Hum. Gene Ther., 1999, 10 (5), 775.
363. Ferkol, T.; Perales, J.C.; Mularo, F.; Hanson, R.W. Receptor-mediated gene transfer into macrophages. Proc. Natl. Acad. Sci. USA, 1996, 93 (1), 101.
364. Li, S.; Tan, Y.; Viroonchatapan, E.; Pitt, B.R.; Huang, L. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am. J. Physiol. Lung Cell. Mol. Physiol., 2000, 278 (3), L504.
365. Choi, Y.H.; Liu, F.; Park, J.S.; Kim, S.W. Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier. Bioconjug. Chem., 1998, 9 (6), 708.
366. Erbacher, P.; Roche, A.C.; Monsigny, M.; Midoux, P. Glycosylated polylysine/DNA complexes: gene transfer efficiency in relation with the size and the sugar substitution level of glycosylated polylysines and with the plasmid size. Bioconjug. Chem., 1995, 6 (4), 401.
367. Sobolev, A.S.; Rosenkranz, A.A.; Smirnova, O.A.; Nikitin, V.A.; Neugodova, G.L.; Naroditsky, B.S.; Shilov, I.N.; Shatski, I.N.; Ernst, L.K. Receptor-mediated transfection of murine and ovine mammary glands in vivo. J. Biol. Chem., 1998, 273 (14), 7928.
368. Kim, J.S.; Kim, B.I.; Maruyama, A.; Akaike, T.; Kim, S.W. A new non-viral DNA delivery vector: the terplex system. J. Control. Release, 1998, 53 (1-3), 175.
369. Elfinger, M.; Maucksch, C.; Rudolph, C. Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells. Biomaterials, 2007, 28 (23), 3448.
370. Kaul, G.; Amiji, M. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. Pharm. Res., 2005, 22 (6), 951.
371. Kasahara, H.; Tanaka, E.; Fukuyama, N.; Sato, E.; Sakamoto, H.; Tabata, Y.; Ando, K.; Iseki, H.; Shinozaki, Y.; Kimura, K.; Kuwabara, E.; Koide, S.; Nakazawa, H.; Mori, H. Biodegradable gelatin hydrogel potentiates the angiogenic effect of fibroblast growth factor 4 plasmid in rabbit hindlimb ischemia. J. Am. Coll. Cardiol., 2003, 41 (6), 1056.
372. Gu, D.N., T.; Phillips, M.L., Chandler, L.A., and Sosnowiski, B.A. Matrix-immobilized growth factor gene therapy enhances tissue repair. Wounds, 2004, 16 (1), 34.
373. Kushibiki, T.; Matsumoto, K.; Nakamura, T.; Tabata, Y. Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin. Gene Ther., 2004, 11 (15), 1205.
374. Kushibiki, T.; Matsumoto, K.; Nakamura, T.; Tabata, Y. Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres. Pharm. Res., 2004, 21(7), 1109.
375. Chen, H.; Frankenburg, E.P.; Goldstein, S.A.; McCauley, L.K. Combination of local and systemic parathyroid hormone enhances bone regeneration. Clin. Orthop. Relat. Res., 2003, 416, 291.
376. Fang, J.; Zhu, Y.Y.; Smiley, E.; Bonadio, J.; Rouleau, J.P.; Goldstein, S.A.; McCauley, L.K.; Davidson, B.L.; Roessler, B.J. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA, 1996, 93 (12), 5753.
377. Mosesson, M.W.; Siebenlist, K.R.; Meh, D.A. The structure and biological features of fibrinogen and fibrin. Ann. N. Y. Acad. Sci., 2001, 936, 11.
378. Christman, K.L.; Fang, Q.; Yee, M.S.; Johnson, K.R.; Sievers, R.E.; Lee, R.J. Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer. Biomaterials, 2005, 26 (10), 1139.
379. Andree, C.; Voigt, M.; Wenger, A.; Erichsen, T.; Bittner, K.; Schaefer, D.; Walgenbach, K.J.; Borges, J.; Horch, R.E.; Eriksson, E.; Stark, G.B. Plasmid gene delivery to human keratinocytes through a fibrin-mediated transfection system. Tissue Eng., 2001, 7 (6), 757.
380. Mittal, S.K.; Aggarwal, N.; Sailaja, G.; van Olphen, A.; HogenEsch, H.; North, A.; Hays, J.; Moffatt, S. Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: effect of route of inoculation on immune response. Vaccine, 2000, 19 (2-3), 253.
381. Guo, T.; Zeng, X.; Hong, H.; Diao, H.; Wangrui, R.; Zhao, J.; Zhang, J.; Li, J. Gene-activated matrices for cartilage defect reparation. Int. J. Artif. Organs, 2006, 29 (6), 612.